Trump administration freezes and cuts research funding for US universities

In short: The Trump administration’s second term has canceled and frozen large amounts of federal research money for major US universities, and schools are pushing back in court.

What's going on

The Trump administration has imposed funding cuts and freezes affecting US universities, especially for research linked to diversity, equity, and inclusion (often shortened to DEI), climate change, vaccines, LGBTQ topics, and other areas the administration describes as “woke.” The administration has also tied some actions to campus disputes, including antisemitism concerns and student protests.

Columbia University had about $400 million in grants and contracts canceled. This came after the government opened a Title VI investigation, a civil rights process meant to stop discrimination in programs that get federal money, and the cancellation happened 32 days after the investigation began.

Harvard University had more than $2.3 billion in federal research funding frozen after it refused demands to change parts of university governance, admissions, and DEI programs. A federal judge ruled the freeze illegal in September 2025, saying it infringed free speech. Other universities named in the reporting include Cornell, Northwestern, the University of Pennsylvania, Brown, and Princeton, with funding frozen, threatened, or paused.

The cuts also reach specific programs and agencies. The National Institutes of Health cut $2.7 million from the University of Texas at El Paso for programs supporting underserved students in biological sciences. The National Science Foundation canceled more than 400 active grants, including grants related to DEI, misinformation, and AI, despite a restraining order.

What to watch

More than 200 university presidents have signed a joint statement criticizing the moves as political interference, and several lawsuits are underway. The New York Times notes other countries may try to recruit US scientists, but the available public evidence described here focuses on domestic impacts like funding pauses, legal challenges, and visa revocations, not confirmed large-scale migration.

Source: NYTimes